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Abstract 
Robinson Crusoe Island is a geographically and socially isolated settlement located over 
600km west of the Port of Valparíso, Chile. An unusually high incidence (30%) of the Chilean 
equivalent of developmental language disorder (TEL) has been reported in Islander children, 
with 90% of these affected children found to be direct descendants of a pair of original founder-
brothers, therefore strongly suggesting a shared genetic basis.  
Here we utilise whole-genome sequencing to investigate potential underlying variants in 
a panel of thirty-four genes known to play a role in language disorders, in seven TEL affected 
and ten unaffected islanders. We use this targeted approach to look for rare, shared variants that 
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may underlie the diagnosis of TEL in a Mendelian genetic model. We go on to test whether the 
overall burden of rare variants is enriched in individuals affected by TEL or with Islanders 
related to the founder-brother lineage.  
In the absence of explanatory rare variants, we further investigate these candidate genes 
within a complex model of inheritance, where inheriting a small number of moderate impact 
common variants may increase susceptibility of developing TEL. We examine if any variants 
segregate with affection status or with founder-brother-related status, and therefore may increase 
risk of developing a language disorder. Finally, we perform a pooled, gene-based tests to 
evaluate relationships between combined variation across candidate genes and TEL affection 
status. 
Here we report a comprehensive examination of genes directly implicated in language-
related mechanisms to identify ‘low hanging fruit’ of causative monogenic Mendelian variants, 
and complex association model of increased susceptibility in developmental language disorder 
found on Robinson Crusoe Island.  
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Introduction 
Developmental language disorder (DLD) is the term given to primary childhood language 
disorders, which are not explained by other neurobiological disorders such as autism spectrum 
disorder, developmental delay, or hearing loss (Bishop et al. 2017). DLDs are remarkably 
prevalent and estimated to occur in over 7% of UK school age children (Norbury et al. 2016). In 
real terms, this means there are two to three affected children in every classroom. Even with 
adequate access to speech therapy and educational support, half of children with delayed 
language do not fully catch up with their peers, continuing to struggle with language throughout 
their childhood and into their adult lives (Hulme and Snowling 2009). Children with language 
disorders often struggle academically, and have been shown to have an increased risk of poor 
mental health outcomes, and are more likely to be unemployed in adulthood (Conti-Ramsden and 
Botting 2008).  
Despite the remarkably high prevalence of DLDs, little is understood of the underlying 
aetiology. It is well established that DLD has a strong familial component, supported by twin and 
heritability studies (Stromswold 1998; Bishop et al. 2006; Barry et al. 2007). These familial 
disorders, termed Mendelian disorders, result from inheriting either one (dominant) or two 
(recessive) copies of extremely rare and damaging variants. Which act to disrupt protein 
function. The most well-known and clear-cut examples of Mendelian inheritance in language 
disorders can be found in a motor disorder known as childhood apraxia of speech (CAS), also 
known as developmental verbal dyspraxia. CAS is considered to be a sub-category of DLD that 
specifically refers to difficulties in the fine motor control required to produce and coordinate 
sounds into complete words and sentences, characterised by difficulties in producing speech 
sounds, dysarthric speech and poor oral motor control. The first CAS case to be solved involved 
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a dominant mutation in the gene FOXP2 was found to be shared by all CAS-affected members of 
a large multigenerational pedigree, known as the KE family (Lai et al. 2001). The p.Arg553His 
FOXP2 mutation is fully-penetrant in the KE family, meaning that all carriers have CAS and 
non-carriers do not. A number of subsequent studies have identified additional FOXP2 mutations 
in other unrelated individuals as the cause of CAS (MacDermot et al. 2005; Tomblin et al. 2009; 
Turner et al. 2013; Moralli et al. 2015; Liegeois et al. 2016; Reuter et al. 2017) providing further 
evidence of the gene’s role in language. A small number of other genes have also been 
implicated in the CAS phenotype. One such gene is the protein transporter ERC1 (Thevenon et 
al. 2013) which was identified by overlapping 12p13.33 deletions in five unrelated CAS cases.  
The CAS phenotype is considered extremely rare, and very few children are found to 
carry causative variants in FOXP2 or ERC1. It is a similar story with other Mendelian causes of 
DLDs, and there are very few examples of genes where a high impact familial variant is shared 
among affected family members. One such example is the transmembrane protein encoding gene 
TM4SF20, in which a deletion of the second last exon leads to DLD and white matter hyper-
intensities (Wiszniewski et al. 2013). The heterozygous deletion, found in children of mainly of 
South East Asian descent, was reported to show near-complete penetrance, meaning that deletion 
carriers were extremely likely to have a DLD phenotype.  
Clear-cut Mendelian causes of language disorders are still relatively rare and are the 
exception rather than the rule. More commonly, genes are implicated in comorbid, overlapping 
disorders such as dyslexia, autism spectrum disorder and intellectual disability syndromes, still 
with DLD as a prominent feature as part of a complex disorder. A recent illustrative example is 
the identification of chromatin modelling gene CHD3 (Snijders Blok et al. 2018). Mutations 
which led to changes in the ATPase/helicase domains of this protein resulted in CAS, 
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accompanied by intellectual disability, and macrocephaly in 35 unrelated individuals. Mutations 
in CHD3 result in a more global neurodevelopmental syndrome rather than a language specific 
phenotype.   
Similarly, mutations in the glutamate-gated ion channel gene GRIN2A can result in 
dominant DLD and epilepsy, with or without intellectual disability (Endele et al. 2010; Carvill et 
al. 2013). The CAS and DLD phenotypes found seen in these CHD3 and GRIN2A examples are 
considered to be a primary feature of the disorder, as opposed to a secondary deficit of a more 
complex disorder. They do, however, reflect a difference in opinion of what constitutes a 
primary language disorder compared to a secondary feature of a broader neurodevelopmental 
syndrome. As there are very few genes which result in primary language disorders, genes 
implicated in syndromic neurodevelopmental disorders represent a substantial increase in our 
understanding of the genetic aetiology of language.  
The family-based studies described above can provide starting points in understanding 
the biological base of language disorders through the identification of rare Mendelian variants. It 
is, however, not the case that the Mendelian inheritance model fully explains the underlying 
genetics of all DLDs. As genetic technologies and knowledge develops, we are slowly building a 
picture of genetic susceptibility within a complex inheritance model; where a number of variants 
are inherited together, interacting in particular environmental and cellular circumstances to result 
in a language disorder phenotype. These ‘risk’ variants are likely to be much more common in 
the population (minor allele frequency (MAF) ≥5%) and confer a moderately damaging effect. 
This contrasts with Mendelian recessive and dominant variants which tend to be extremely rare 
in the population (MAF≤1%) and are much more damaging to the resulting protein.  
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When inherited in combination with other ‘risk’ variants, they can combine together to 
become damaging and result in the DLD phenotype. This is more akin to cancer or diabetes; 
where there are a number of more common risk variants that interact with environmental factors. 
These risk variants each confer a small increase in an individual’s susceptibility to develop a 
particular disorder. Our understanding of the role of genetic risk factors in language disorders 
lags behind other neurological disorders such as schizophrenia and autism spectrum disorder 
(ASD), which are much better characterised.  
One of the best characterised examples of risk variants in language are in the gene 
CNTNAP2, which was first identified as a candidate for DLD through its functional interaction 
with FOXP2 (Vernes et al. 2008). The CNTNAP2 gene encodes a neurexin-family synaptic 
protein and has been found to be associated with DLD (Devanna et al. 2017), epilepsy (Zweier et 
al. 2009) and ASD (Alarcon et al. 2008; Arking et al. 2008; Bakkaloglu et al. 2008). Other 
language-implicated genes have been found to associate closely with related comorbid disorders, 
suggestive of overlapping disease aetiology. This underlying comorbidity appears to be the rule 
rather than the exception.  
Genes associated with language disorders and comorbid phenotypes, as well as details of 
the methods used to identify them, are reviewed in Chen et al. (2017), Deriziotis and Fisher 
(2017) and Mountford and Newbury (2018).  
In reality, both rare damaging and common variants are likely to contribute to DLD. This 
can make the identification of novel variants challenging. The detection of common variants 
requires large (tens of thousands) of individuals all phenotyped in the same way. Family-based 
studies genetic studies are performed on a much smaller scale, but variants identified in one 
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family tend to be extremely rare, and unlikely to replicate in other pedigrees. To narrow the 
genomic regions in which to look for the candidate variants, a pedigree needs to contain both 
affected and unaffected individuals, and include as many second-degree relatives as possible. 
Extensive pedigrees provide exceptional opportunities to narrow down the regions shared by 
affected individuals (and not shared by unaffected individuals), ultimately narrowing the search 
space that contains the causative variant.  
An exceptional example of a large pedigree with DLD comes from Robinson Crusoe 
Island (RCI). RCI is geographically and socially isolated, located over 600km off the coast of 
Chile. Islander children have an exceptionally high occurrence rate (62.5%) of speech and 
language disorder. Half of the cases (56%) have language delay in isolation with no evidence of 
intellectual disability, or other neurological disorders that may affect language ability 
(Villanueva et al. 2008; De Barbieri et al. 2018). This specific type of language disorder is 
named Trastorno Especifico de Lengauje (TEL). The Chilean term which when translated to 
English means ‘language specific disorder’ (De Barbieri et al. 2018). The remainder present with 
more generalised developmental or neurological disorders in which language delay is a 
secondary feature of an overlapping related disorder (e.g. ASD, developmental delay). 
RCI provides a unique cohort in which to study the genetics of language disorders; a 
geographically isolated population, founded in 1876 by 64 individuals. The current population 
has over 800 inhabitants, with a high consanguinity rate (14.9%) (Villanueva et al. 2014). This 
means that risk alleles that have been inherited from original founders may be greatly enriched in 
the current cohort, providing substantial power to detect contributory variants. The strength of 
this population is in the consanguinity and isolated nature of the population, despite relatively 
modest sample numbers. Previous gene dropping simulations reported in Villanueva et al (2015) 
8 
 
within the observed pedigree structure indicate that causal allele frequencies will be consistently 
and significantly elevated above expected for a range of allele frequencies and founder allele 
combinations, and even rare (1%) founder alleles will be greatly enriched (13%) in the current 
cohort. 
A previous study of the RCI population used whole exome sequencing to identify a rare 
nonsynonymous p.Asp150Lys (rs144169475, chr4:g.47,907,320A>T hg19) variant in the nuclear 
transcription factor X-box binding-like 1 gene, NFXL1 (Villanueva et al. 2015). This variant was 
found to be enriched in islanders with the TEL phenotype (39%) compared to those with typical 
language development (TLD) (10%) (p=2.04x10-4) and accounted for 7% of the trait variance 
seen on the island (Villanueva et al. 2015). Although strongly associated with TEL, this variant 
was found to occur in language-typical Islanders and was not present in all TEL individuals. It 
therefore only explains part of the TEL occurrence in this population. 
The p.Asp150Lys variant was reported by (Villanueva et al. 2015) was detected in 4.2% 
of the 320 Chilean and Columbian controls tested (27/640 alleles tested), and not detected at all 
in European controls (0/254 alleles tested). Villanueva and colleagues also showed that rare 
coding variants in NFXL1 were enriched in a cohort of 117 unrelated cases from the UK-based 
Specific Language Impairment Consortia cohort. While this replication cohort is small in sample 
size, it provides further independent evidence for the role of NFXL1 in language disorders.  
Since this publication, additional population data has become available through the 
gnomAD database (Lek et al. 2016), showing the variant is present at an allele frequency of  
5.047% in Latinos (AMR) (1772/35,112 alleles tested) and includes 57 homozygotes. The 
variant is still extremely rare in people of European decent (0.00078%) (1/126,384 alleles tested) 
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and across all gnomAD populations it is 0.65% (1825/281,822 alleles tested) and is therefore still 
considered to be extremely rare variant. As the Robinson Crusoe Islanders are predominantly of 
Chilean ancestry, then careful selection of relevant population specific allele frequencies are 
important when trying to understand the effect of a variant. As larger control sample sets become 
available, more accurate estimates of allele frequencies can be derived. In this instance, the allele 
frequency of the p.Asp150Lys variant is still enriched in Islanders compared to the Latino 
population in general - 11.3% compared to 5% respectively. The incidence of this risk allele is 
significantly increased among those Islanders affected by TEL (19.4%) (Villanueva et al. 2015). 
It is, however, clear that this variant alone does not explain the entire risk. Instead, we propose 
this variant is a genetic modifier, conferring a moderate increase in risk of TEL and may act 
alongside another, as yet undiscovered, rare damaging variant.      
Given the pedigree structure and isolated nature of the RCI population, it is hypothesised 
that the speech and language disorders present on RCI are caused by rare (minor allele frequency 
(MAF) of ≤1%) genetic mutations with a high-risk effect, or by combinations of genetic variants 
that together confer a high risk. Although previous publications have presented exome sequence 
data in this population, a full assessment of the entire genome has yet to be made. In the current 
study, we use whole-genome sequence data from 7 TEL and 10 typical language development 
(TLD) islander individuals to fully assess the role of rare and damaging variants in genes 
implicated in language disorders, including those associated with both primary language 
disorders and overlapping syndromes. We will examine whether rare and common variants in 
these thirty-four language candidate genes are risk factors for TEL in this extensive pedigree 
through association analyses. This whole-genome sequencing approach provides complete 
capture of the gene regions, covering coding exons, untranslated and intronic regions in its 
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entirety, enabling a comprehensive assessment of existing candidate genes within this 
population.   
Villanueva et al. (2014) ascertained near-complete genealogical records of the RCI, and 
using this resource found that 90% of islander children with TEL are directly descended from a 
pair of original founder-brothers. Based on this finding, we further investigate variants patterns 
in founder-brother-related individuals allowing us to evaluate the hypothesis that causative 
variants may be shared or over-represented in founder-brother-related TEL individuals, thus 
contributing to an increased incidence of language disorder. Both rare and common variants in 
these thirty-four language candidate genes will be tested for segregation, enrichment and 
association in founder-brother-related-islanders.  
 
Materials and Methods 
Participants were assessed in line with current diagnostic practices set by the Chilean 
Ministry of Education, and described in detail in De Barbieri et al. (2018). The ethics department 
of the University of Chile approved the project “Genetic analysis of language-impaired 
individuals from the Robinson Crusoe Island” – Project Number 001-2010. Informed consent 
was given by all participants and/or, where applicable, their parents. The test battery was 
performed in Chilean Spanish, by native speakers, who assessed phonological production 
(TEPROSIF-R) (Pavez G et al. 2008), expressive and receptive morphosyntax (Toronto Spanish 
Grammar Exploratory (TGE) test) (Pavez MM 2003), and non-verbal intelligence (Columbia 
Mental Maturity Scale) (Burgemeister et al. 1998). Children met the criteria for a diagnosis of 
TEL if they fell either 2SD below the expected score, or more than two years below the score 
expected for their age (TEPROSIF-R), below the 10th percentile (TGE test), and had a neuro-
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typical non-verbal IQ score above the 10th percentile. Individuals describe as having typical 
language development (TLD) scored more than 2SD below expected and more than two years 
below their expected age (TEPROSIF-R test), above the 10th percentile (TGE test), and above 
the 10th percentile on the non-verbal IQ test.   
Adults were assessed on verbal fluency using the Barcelona test (Peña-Casanova et al. 
1997), verbal comprehension using the Token test (De Renzi and Vignolo 1962), and non-verbal 
ability using the Raven progressive matrices (Raven 2003). TEL adults scored below the 10th 
percentile on either the verbal fluency or verbal comprehension, and above the 10th percentile in 
the non-verbal IQ score. TLD adults scored above the 10th percentile on all three measures. 
Diagnostic criteria and language assessments were set as reported in De Barbieri et al 2018. 
Seventeen islanders were selected for sequencing based on the most distantly related and 
therefore most informative individuals representing affected (TEL) and unaffected (TLD) 
phenotypes. Whole-genome sequencing performed by Oxford Genomics using Nimblegen™ 
capture and sequenced on the Illumina HiSeq platform with 98.2% of bases covered to a 
minimum coverage of 10x and 88.53% covered to 20x. Quality control and sequence alignment 
(to build hs37d5) were performed by the Oxford Genomics service using their standard analysis 
pipeline.   
Variant calling was performed using Platypus (Rimmer et al. 2014) and GATKv3.5-0 
(Van der Auwera et al. 2013) using best practises. Bcftools 1.2 and htslib-1.2.1 
(http://github.com/samtools/bcftools) were used to intersect high confidence variants called by 
both algorithms. PASS variants were filtered using VCFtools 0.1.14 (Danecek et al. 2011). 
Additional hard filtering was used to filter variants with a map quality (MQ) score of ≥40, total 
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allele count (AN) of ≥26, and total read depth (DP) of ≥140 across all 17 samples using Bcftools 
1.7 and htslib-1.2.1 (http://github.com/samtools/bcftools). Variant calls, in VCF format, were 
split and left aligned using Bcftools to ensure one variant per line, and therefore compatibility 
with downstream applications.  
The list of genes implicated in language disorders, and by proxy language, was obtained 
from the literature, previously reviewed in Chen et al. (2017), Deriziotis and Fisher (2017), and 
Mountford and Newbury (2018). Additionally, we included CHD3 which was reported in 
(Snijders Blok et al. 2018), plus six novel candidate language genes (KAT6A, MKL2, SETD1A, 
TNRC6B, WDR5, and ZXHF4) recently reported in Eising et al. (2018). Complete canonical gene 
region coordinates, including the entire annotated 5’ and 3’ untranslated regions, were obtained 
from UCSC Genome Browser hg19 build (https://genome-euro.ucsc.edu) (supplementary Table 
1), and variants falling within these thirty-four regions were extracted from the VCF using 
VCFtools 0.1.15 (Danecek et al. 2011).  
Variant annotation was performed using Annovar (release 2018Apr16) (Wang et al. 
2010) with dbSNP (avsnp150), splice site prediction (dbscSNV version 1.1), variant 
pathogenicity prediction (dbSNP35a), ExAC exomes allele frequency data (2015 release) (ALL 
n=125,748), gnomAD genome collection (v2.0.1) (ALL n=15,708, Admixed American (AMR) 
n=424, non-Finnish European (NFE) n=7,718), 1000 Genomes Project (1000g2015aug) allele 
frequencies (ALL, AMR, and EUR (European)), and Clinvar version 20180603 databases (hg19 
build).  
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Variant filtering and prioritisation was performed using Linux command line to identify 
potentially causative variants that are shared between all TEL or all founder-brother-related 
individuals using both recessive and dominant inheritance models.  
Rare variants with a minor allele frequency of ≤1% in gnomAD AMR whole-genome 
population data, and falling within a language gene region (coding, intronic and UTR) were 
tested for enrichment in affected (TEL or founder-brother-related individuals) using students T-
test.  
Segregation analysis was performed on all variants (both rare and common) to test for 
variants which showed complete segregation between TEL affected individuals but not with 
TLD individuals. This approach was also used to identify variants that were shared by all 
founder-brother-related individuals and not shared by non-founder-brother-related individuals.   
To test for the effect of all variants (rare and common) acting in combination in an 
individual gene, a gene-based association test was performed using the SKAT test in RVTESTs 
(Zhan et al. 2016) on all variants falling within the gene region (coding, intronic and UTR). 
Association testing was performed on both SNVs and indels, excluding those in HWE ≤1x10-5 
which was calculated in Plink 1.90 (Purcell et al. 2007). Thresholds for statistical significance 
were set by Bonferroni correction, to account for multiple testing.  
A flow diagram of the workflow and statistical analyses is shown in Figure 1.  
 
Results 
Sequencing of Language Gene Regions 
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A total of thirty-four genes implicated in language disorders (and therefore language) 
were identified through a combination of current literature reviews (Chen et al. 2017; Deriziotis 
and Fisher 2017; Eising et al. 2018; Mountford and Newbury 2018; Snijders Blok et al. 2018). 
The combined thirty-four language gene regions spanned a target region of 12.6 Mbp. Variants 
annotated by Annovar as ‘non-coding RNA’ were excluded from analysis, which included all 
variants contained within in ABCC19, and it was therefore excluded from further analysis 
resulting in only 33 genes remaining. After variant calling, a total of 33,966 non-reference calls 
were identified within the selected gene regions (exonic, intronic, untranslated (UTR), and 
potential splice sites (±3bp)). This consisted of 29,510 single nucleotide variants (SNVs) and 
4,458 small insertions and deletions (indels). Sequenced individuals had a median of 13,817 
variants calls (range=12,902-16,610) (Table 1).   
 
Rare Mendelian Variant Analysis 
We first performed a search for variants contained with potential for a clear functional 
impact, therefore contained only within exons or potential splicing site regions. 137 (129 SNVs, 
8 indels) variants were detected (median=41, range=33-52).   
To further narrow these to potential variants of interest, variants predicted unlikely to 
have an amino acid of the protein (synonymous (74 variants) or nonframeshift indels (7 
variants)) totalling 81 variants were dropped from the analysis. This left a total of 56 variants, 
consisting of one potential splice region variant, one stop-gain, one frameshift insertion and 53 
missense variants (median=16, range=10-22) (Table 1).  
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Finally, to identify novel or extremely rare variants that may be impacting on the TEL 
phenotype, variants were excluded if they had a minor allele frequency (MAF) of more than 1% 
(MAF ≥0.01) in the gnomAD AMR population and more than 5% (MAF ≥0.05) in the gnomAD 
ALL dataset. A total of fifteen rare and nonsynonymous variants were identified in the 17 
sequenced islanders (median=1, range=0-3), spanning ten different genes (Table 2).   
To assess a potential impact of these prioritised variants, and therefore their potential 
pathogenicity, functional annotations were investigated. All 15 variants were missense SNVs, 
with no loss of function variants (stop-loss, stop-gain, or frameshift) being prioritised. Similarly, 
no potentially damaging splice site mutations were found to be rare (MAF≤0.01).  
None of the prioritised rare nonsynonymous variants were found to segregate with either 
TEL status or were shared by the direct descendants of the founder brothers. These findings 
indicate there is no single high impact Mendelian variant in previously reported language genes 
that fully explains the TEL phenotype in the RCI population. The rare and nonsynonymous 
variants detected spread across many of the candidate genes and were found in both TEL and 
TLD individuals alike, often occurring in a single individual. Six rare nonsynonymous variants 
were found only in TEL individuals. These occurred in the ROBO1, NFXL1, KIAA0319, ERC1, 
ATP2C2, and TNRC6B genes. Six further rare variants were found only in TLD individuals. 
These were contained in CNTNAP5, ROBO2, KAT6A, ZFHX4, MKL2 and ATP2C2. Finally, 
three variants were found in both TEL and TLD individuals with two found in ROBO2 and one 
within ZFHX4. 
All fifteen of the prioritised variants were missense, single base pair changes rather than 
indels, and therefore the a in silico missense pathogenicity prediction score could be used to 
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interpret potential pathogenicity. To investigate the functional impact of these missense 
mutations, variants were flagged as potentially damaging if they were predicted to be damaging 
by at least seven of ten variant prediction tools (SIFT, Polyphen2, Polyphen2_HDIV, LRT, 
MutationTaster, MutationAsseser, FATHMM, Provean, MetaSVM and MetalLR). Only one of 
the fifteen variants met these criteria, c.C256T (p.Arg86Trp) in ATP2C2, which was detected in 
a homozygous state in a single individual with typical language development (TLD-2). This 
variant is unreported (MAF=0.0000) in the AMR and ALL genome control populations and is 
extremely rare (MAF=0.00001658) in the ExAC ALL dataset (n=125,748). It has not previously 
been reported in a homozygous state. While this is a likely functional variant in a gene of 
interest, as it was identified in an unaffected individual and so is unlikely to play a role in the 
language disorder seen on RCI.   
We can therefore conclude that there is no causal variant within a language-implicated 
gene that is solely responsible for the language phenotype seen in the RCI. Nonetheless, it 
remains possible that Islanders may have a genetic susceptibility resulting from combinations of 
rare and/or common variants each conferring a moderate effect size. 
Rare Variant Burden Analysis 
To examine whether an overall burden of rare variants across the entire gene regions 
(inclusive of exons, introns, UTRs and potential splice variants) were contributing directly to 
TEL affection status, or were enriched in founder-brother related individuals, rare variants (≤1% 
in AMR genome population data set) were subset across the full gene regions. A total of 4,998 
rare (≤1% in gnomAD AMR) variants were detected across the 33 language genes (12.6Mb) in 
17 sequenced islanders, with a mean of 435 rare variants (1 rare variant every 29Kb) 
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(median=340, range=266-732) (Table 3). Interestingly, the TLD group (n=10) were found to 
harbour a higher number of rare variants across the thirty-three language genes than the TEL 
group (n=7). The TEL group had a mean of 390.5 rare variants, compared to 466.1 found in the 
TLD group. A student’s t-test indicated that this group mean difference was not significant 
(p=0.3558).  
To investigate whether direct descendants of the founder-brothers carry a higher number 
of rare variants within the language genes and are therefore at a higher risk of developing 
language difficulties, a test of variance was performed on the founder-brother-related group 
(n=14) compared to the non-founder-brother-related group (n=3). The founder-brother-related 
individuals carried a higher mean number of variants (mean=456.79) compared to the non-
founder brother related individuals (mean=333.33) although this did not reach significance 
(p=0.0743). These findings therefore indicate that combinations of rare variants across the 33 
genes are unlikely to be responsible for the developmental language disorder seen on RCI. 
Variants Segregation Analysis 
Initial exploration of the genome data focussed on rare variants. To explore the role of 
common variants, we assessed all 33,966 SNVs and indels from thirty-three language genes. In 
the absence of co-segregating rare variants, we applied a wider analysis that included all variants 
across the language-candidate genes. All 33,966 SNVs and indels from thirty-three language 
genes were assessed for co-segregation in the founder-brother-related individuals (TEL n=6, 
TLD=8).  
Three hundred and twenty-seven variants were found to be homozygous across all six 
TEL founder-brother-related individuals and 54 variants were found to be heterozygous in all six 
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TEL founder-related individuals. However, all these variants were also found to occur in TLD 
individuals. One variant, an intronic SNV in CNTNAP5 (rs9309831), was found to occur in a 
homozygous state in all 6 TEL cases. However, this variant was also found in a homozygous 
state in three TLD participants and in a heterozygous state in the remaining 5 TLD participants. 
Upon further investigation, this variant was found to have a minor allele frequency of ≥0.9. Five 
intronic variants (rs779979, rs779980, rs7605310, rs13402327 and rs2565748), all in CNTNAP5, 
were found to be heterozygous in all TEL cases, but were also observed in a heterozygous state 
in 4 of the 8 TLD participants. 
These five intronic variants identified in CNTNAP5 may be inherited together in a 
haplotype block, increasing susceptibility of TEL. To investigate if these variants fall within a 
shared region, we produced a genotype grid in order to visualise the region (Figure 2). The 
genotype grid shows there is no clear region shared between the TEL founder-brother related 
individuals, and there are a large number of non-segregating variants between the five variants. 
The lack of clear genotype segregation in the CNTNAP5 region suggests it is not associated with 
TEL affection status in founder-brother related individuals.  
Gene-based Analysis of Common and Rare Variants 
Finally, to assess the possibility of a complex genetic mechanism, we performed gene-
based association analyses of all variants (common and rare) across the language candidate 
genes. Collapsing variants into gene-regions allows for signals that may not be directly covered 
by the sequencing (upstream variants of a gene) and will improve detection of this signal by 
combining all variants into a gene-based test. Therefore, a statistically significant gene-based test 
is a strong indication of genetic contribution to TEL in this population, at a whole-gene level. 
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Thirty-three genes containing 33,966 identified variants were tested using the kernel based 
SKAT test of association in the RVTESTs package (Zhan et al. 2016).  
When using the TEL status as a categorical variable, no genes (Table 4) reached 
statistical significance (Bonferroni corrected p=0.00073), and only one gene, NOP9, was 
nominally significant (p=0.0407). 
To assess whether complex patterns of variants are enriched in original founder-brother-
related individuals, we repeated the SKAT test in founder-brother-related against non-founder-
brother-related individuals. Again, no gene was significantly associated after a Bonferroni 
correction (p=0.00073). Two genes (DYX1C1 and SETBP1) had p-values <0.01 (p=0.0097 and 
p=0.008 respectively), with a further four genes (FOXP1, MKL2, RBFOX2 and SETD1A) were 
found to be nominally significant at p≤0.05.  
 
Discussion 
Robinson Crusoe Island is an isolated population of admixed Chilean and European 
ancestry reports to have an unusually high incidence of language disorder, termed TEL in Chile. 
Near-complete genealogical records indicate that 90% of affected Islander children are direct 
descendants of a pair of original founder-brothers, strongly suggesting a genetic founder effect 
(Villanueva et al. 2008; Villanueva et al. 2011; Villanueva et al. 2014; Villanueva et al. 2015).  
This study utilised whole-genome sequencing to comprehensively investigate variation 
across thirty-three genes previously implicated in language-related phenotypes in TEL affected 
(n=7) and TLD unaffected (n=10) Islanders.  
20 
 
Based on the high degree of relatedness and therefore shared genetics of the Islanders, we 
postulated that a rare (MAF ≤1% in gnomAD AMR) high impact variant may underlie TEL 
affection on RCI. Fifteen rare nonsynonymous variants in eleven genes were identified in the 
sequenced individuals. However, no single variant segregated with TEL status. Interestingly, the 
only variant with a potential pathogenicity prediction was found in a homozygous state in TLD-2 
an unaffected individual. No single pathogenic variant within the language gene regions was 
detected.    
A wider investigation of rare variants (MAF ≤1% in the gnomAD AMR population 
controls) across the entire gene regions (including introns) did not find any evidence of increased 
variant burden in TEL individuals compared to those with TLD (p=0.3558). In fact, the TLD 
group were found to carry a higher number of rare variants, although this was not statistically 
significant. Interestingly, a moderate enrichment of rare variants was observed in the founder-
brother-related individuals. As the sample size is highly limited, this may be artificially inflated 
by the small number of non-founder-brother-related individuals sequenced (n=3). 
In the absence of co-segregating rare variants, we extended our investigation and 
considered all variants observed across the candidate genes (n=33,966). Again, no variant was 
found to fully segregate with affection status. Interestingly, six intronic CNTNAP5 variants were 
found to occur in a homozygous (rs9309831) or heterozygous (rs779979, rs779980, rs7605310, 
rs13402327 and rs2565748) state in all TLD individuals investigated. However, these variants 
were also observed in TLD individuals and genotype analysis showed there was no clear 
haplotype that segregated with TLD affection within the founder-brother-related individuals.  
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Finally, we assess all variants within a gene-based burden analysis. Again, no association 
was found to either TLD status or founder-brother-relatedness. Several genes reached nominal 
significance, potentially suggesting a multi-loci complex genetic signal however the small 
number of non-founder-related individuals may increase statistical bias.  
In conclusion therefore, our results indicate either a single hit variant or a general burden 
of variants within known candidate language genes do not explain the risk of TEL in the RCI 
Islanders. No single variant was found to co-segregate with language or founder-brother-related 
status and no gene showed any evidence of increased burden in relation to TEL.  
Interestingly, the NFXL1 gene, which was identified as a risk-gene within the RCI 
population by Villanueva et al. (2015), did not show association to TEL in the current study. The 
p.Asp150Lys risk variant was not included in the rare variant analyses presented here as it has a 
gnomAD frequency greater than 1%  and, as previously reported (Villanueva et al. 2015), the 
variant does not show complete segregation with TEL status. It should be noted that the cohort of 
islanders sequenced in this paper is much smaller than that genotyped for p.Asp150Lys in the 
Villanueva (2015) paper, which represents a much more complete characterisation of this 
variant. Information regarding the frequency of this variant across control population is now 
more extensive and is estimated at MAF=0.0504 (AMR) and MAF=0.006476 (ALL) clearly 
indicating the variant is more common in people with Latino ancestry. Nonetheless, the previous 
research stands and even with these updated population data, this variant remains enriched 
among Islanders and TEL individuals and, as such, still represents an excellent candidate risk 
variant in the RCI population.  
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The lack of association to the NFXL1 variant in the current study is likely explained by 
the small sample size. Only 3/7 TEL cases carried the NFXL1 variant compared to 3/10 TLD 
controls, by chance fewer than expected. At a genome wide level, the p.Asp150Lys NFXL1 
variant was found to account for 7% of the trait variance seen on RCI (Villanueva et al. 2015), 
suggesting this variant may be a modifier to a dominant model, or play a role in a complex 
susceptibility model. Our data do not contradict this finding but show a need for improved 
sensitivity through increased statistical power.  
Whole-genome sequencing is a useful method for identifying the variants underpinning 
genetic disorders and provides an unprecedented range of genetic information in one test. As 
whole-genome sequencing becomes more common, the major bottleneck is the analysis of the 
huge volume of data generated from a sequencing run and narrowing variants of interest from the 
vast numbers of non-reference variant calls detected in each individual. This means, that even 
with extensive phenotypic and familial information, it can be difficult to narrow the cause of 
disease. One practical approach to thinning the number of potential causative variants is to 
combine the usage of candidate genes already implicated in the disorder, in combination with 
pedigree information to look for segregating variants. In large, complex pedigrees like Robinson 
Crusoe Island, prioritising variants that segregate with affection status can increase power to 
detect causative variants. These methods allow for the identification of ‘low hanging fruit’: rare, 
nonsynonymous variants that segregate with disease and are in genes already implicated in 
language. Whole-genome sequence analysis, particularly in a large and complex family like RCI, 
can be challenging and technically non-trivial, therefore this approach is a sensible first place to 
start.  
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Similar family and genealogy-based methodologies have been successfully applied to 
other related population in which language disorders are common. (Wiszniewski et al. 2013) 
identified an ancestral deletion of exon 3 in the gene TM4SF20 that is present in ~1% of people 
with South East Asian ancestry. They found that this deletion strongly increased the risk of 
language disorders with or without white matter hyperintensity. Similarly, (Kornilov et al. 2016) 
reported the association of SETBP1 with DLD in a Russian population from an isolated village 
where they found a remarkably high occurrence rate of ~30%.  
We have shown that the TEL seen on Robinsons Crusoe Island is not caused by a single 
shared Mendelian mutation in known language candidate genes and have comprehensively tested 
for ‘low hanging fruit’. Founder-brother related individuals may have a subtle ‘risk’ profile from 
a small number of moderate effect variants as part of a complex model however we did not 
detect a robust association with any of the thirty-three language genes tested. Therefore, the 
underlying cause of TEL on RCI is likely due to a Mendelian variant in a novel gene that is yet 
to be associated with language, or alternatively a complex susceptibility model that we lacked 
the power to detect.   
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Tables 
Table 1 shows the numbers of variants found in the language gene regions by whole-genome 
sequencing, if the individual is directly related to the pair of original founder brothers, and 
whether they carry the p.Asp150Lys NFXL1 variant. A) Results for the Typical Language Delay 
(TLD) control group, and B) results for the language disorder affected (TEL) group. C) The 
median number of variants for each level of filtering (Median), and the range across all 17 
individuals.  
  
A
Number of variants identified in: TLD-1 TLD-2 TLD-3 TLD-4 TLD-5 TLD-6 TLD-7 TLD-8 TLD-9 TLD-10
Full regions 13,764 14,124 13,817 16,610 15,433 14,036 13,388 12,902 12,261 13,804
Coding 40 33 45 54 52 33 32 44 34 42
Nonsynonymous variants 15 14 18 20 19 14 10 15 10 17
Rare (≤1%) nonsynonymous variants 1 1 1 1 2 0 1 1 0 0
Founder brother related Y Y Y Y Y Y Y Y N N
NFXL1 p.Asp150Lys carrier 0/1 0/1 0/1 0/0 0/0 0/0 0/0 0/0 0/0 0/0
B
Number of variants identified in: TEL-1 TEL-2 TEL-3 TEL-4 TEL-5 TEL-6 TEL-7
Full regions 14,320 12,918 12,864 15,761 14,129 14,169 12,492
Coding 35 44 51 47 41 32 37
Nonsynonymous variants 16 14 18 22 16 11 17
Rare (≤1%) nonsynonymous variants 1 1 2 3 2 0 0
Founder brother related Y Y Y Y Y Y N
NFXL1 p.Asp150Lys carrier 0/1 0/1 0/1 0/0 0/0 0/0 0/0
C
Number of variants identified in: Total Median
Full regions 33,968 13,817
Coding 137 41
Nonsynonymous variants 56 16
Rare (≤1%) nonsynonymous variants 15 1
33-52
10-22
0-3
Typical Language Delay Controls
Language Disorder Affected Cases
Range
12,902-16,610
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Table 2 shows prioritised rare, nonsynonymous variants identified in the thirty-three language 
genes in 17 Robinson Crusoe Islanders, 7 with a diagnosis of TEL and 10 unaffected individuals 
(TLD). The table includes the genomic location (chromosome and position) of the variants, the 
gene in which it falls, the resulting coding and amino acid changes, and the transcript and 
corresponding exon. The rsID column indicates the dbSNP identifier, and no record is indicated 
by a full stop. The Pred. lists the combined in silico missense pathogenic prediction score 
(maximum score of 10). gnomAD MAF indicates the sum of minor allele frequencies list in the 
gnomAD database for the Latino (AMR) and combined (ALL) populations. No data, meaning an 
allele has not been detected in the control populations, is indicated by a full stop. Finally, the 
genotype of individual for each variant is indicated as wild-type (0/0), heterozygous (1/0) or 
homozygous (1/1).   
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Table 3 shows the total number of rare variants found in the sequenced Robinson Crusoe 
Islanders across the entire gene region of the thirty-three language genes. A. The total number of 
rare variants per individual. B. The mean number of rare variants per group; TEL compared to 
TLD, and founder-brother-related compared to non-founder-brother-related, and the Students t-
test to test for a statistical difference in means between the two groups.  
 
  
A
Sample TEL-1 TEL-2 TEL-3 TEL-4 TEL-5 TEL-6 TEL-7 Total variants = 4998
No. Rare Variants 445 340 320 732 291 340 266 Total mean variants = 362.32
Founder brother related Yes Yes Yes Yes Yes Yes No Standard deviation = 164.52
Sample TLD-1 TLD-2 TLD3 TLD-4 TLD-5 TLD-6 TLD-7 TLD-8 TLD-9 TLD-10
No. Rare Variants 345 686 293 722 645 400 470 366 406 328
Founder brother related Yes Yes Yes Yes Yes Yes Yes Yes No No
B
390.571 456.786
TLD unaffected mean = 466.1 333.333
0.35575 0.07431Students t-test p=Students t-test p=
TEL affected mean =
TEL Affected
TLD Controls
Founder brother related n=14, unrelated n=3
Founder related mean =
TEL n=7, TLD n=10
Founder unrelated mean =
33 
 
Table 4 shows the gene-based association testing results using the SKAT test (RVTESTS) 
collapsed into gene regions. The number of variants tested within each gene, and permuted p 
values for each measure are reported. The greyed highlights represent nominally significant gene 
results.  
  
Gene No. of Variants TEL Founder-Brother Status
ARHGEF39 15 0.730112 0.578505
ATP2C2 664 0.52521 0.203707
AUTS2 2661 0.961538 0.408514
BCL11A 177 0.873362 0.881289
CHD3 41 0.632511 0.573808
CMIP 946 0.680272 0.355643
CNTNAP2 8008 0.979432 0.220699
CNTNAP5 3164 0.668896 0.05785
DCDC2 802 0.453721 0.254134
DOCK4 1251 0.779423 0.228042
DYX1C1 30 0.925255 0.0097
ERC1 1956 0.979432 0.168808
FLNC 49 0.623053 0.456313
FOXP1 1390 0.845309 0.03645
FOXP2 481 0.275482 0.122056
GRIN2A 1733 0.585187 0.266962
GRIN2B 1361 0.207107 0.07865
KAT6A 218 0.983284 0.670584
KIAA0319 347 0.118494 0.0951
MKL2 348 0.965251 0.0343
NDST4 776 0.996016 0.464419
NFXL1 50 0.744039 0.194515
NOP9 18 0.0407 0.286312
RBFOX2 449 0.390168 0.026
ROBO1 3303 0.961538 0.338305
ROBO2 2289 0.904977 0.483285
SEMA6D 139 0.639475 0.733113
SETBP1 325 0.910747 0.008
SETD1A 53 0.88879 0.0424
TM4SF20 80 0.588928 0.253887
TNRC6B 290 0.462535 0.11708
WDR5 179 0.352983 0.3397
ZFHX4 373 0.0565 0.653796
SKAT Association Test Permuted P value
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Figures (on individual pages) 
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Figure Captions (as a list) 
Figure 1 shows the analysis work flow from whole-genome sequencing variant calls in 17 TEL 
and TLD Robinson Crusoe Islanders. The variant filtering steps for the Rare Mendelian Variant 
Analysis are highlighted in grey (left). Rare variant burden, segregation and gene-based 
association analyses are described in the black boxes (right). 
 
Figure 2 shows the genotype grid for the founder-brother related TEL and TLD individuals 
across the chr2:125,078,104-12,5086,667 region of CNTNAP5. The five prioritised variants from 
the segregation analysis are indicated by an asterisk. The genotype for each variant in the region 
are indicated as wild-type (orange), heterozygous (blue) and homozygous (purple). The genotype 
analysis shows affected individuals do not share a clearly defined single haplotype containing all 
five markers, and it therefore is unlikely to represent a causative region.  
  
38 
 
Supplementary Tables 
Supplementary Table 1 
Chrom Start  End  Gene 
2 124782864 125672863 CNTNAP5 
2 60684329 60780633 BCL11A 
2 228226874 228244022 TM4SF20 
3 71003865 71633140 FOXP1 
3 75986645 77699114 ROBO2 
3 78646388 79817059 ROBO1 
4 115748927 116035032 NDST4 
4 47849258 47916680 NFXL1 
6 24171983 24358280 DCDC2 
6 24544332 24646383 KIAA0319 
7 111366164 111846462 DOCK4 
7 114055052 114333827 FOXP2 
7 128470483 128499328 FLNC 
7 145813453 148118088 CNTNAP2 
7 69063905 70257885 AUTS2 
8 41786997 41909505 KAT6A (MYST3) 
8 77593515 77779521 ZXHF4 
9 137001210 137025094 WDR5 
9 35659341 35665278 ARHGEF39 (C9orf100) 
12 1100404 1605099 ERC1 
12 13714410 14133022 GRIN2B 
14 24769098 24774374 NOP9 (C14orf21) 
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15 48009584 48066420 SEMA6D 
15 55722506 55800432 DYX1C1 (DNAAF4) 
16 14165196 14360630 MKL2 
16 30968615 30995981 SETD1A 
16 81478775 81745367 CMIP 
16 84402133 84497793 ATP2C2 
16 9847265 10276263 GRIN2A 
17 7788123 7816075 CHD3 
18 42260138 42457379 SETBP1 
21 15646120 15673692 ABCC13 
22 36134783 36424585 RBFOX2 
22 40573929 40731812 TNRC6B 
 
 
